tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market

Elite Pharmaceuticals (ELTP) Revenue

Compare
373 Followers

Elite Pharmaceuticals Revenue

Elite Pharmaceuticals had a revenue of 31.59M in the quarter ending Dec 31, 2025, with -13.03%. This bring the company's revenue in the last twelve months to 140.12M, Decreased 14.02%. In the fiscal year ending Jun 30, 2025, Elite Pharmaceuticals had annual revenue of 84.04M with 48.42% growth.
Revenue (ttm)
140.12M
Revenue Growth
72.67%
P/S Ratio
4.97
Revenue/Employee
$1,313,186
Employees
64
Market Cap
$417.98M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Jun 30, 2025
84.04M27.42M+48.42%
Jun 30, 2024
56.63M-34.10B-99.83%
Mar 31, 2023
34.16B34.12B+105,767.55%
Mar 31, 2022
32.26M6.88M+27.11%
Mar 31, 2021
25.38M7.39M+41.05%
Mar 31, 2020
17.99M10.43M+137.76%
Mar 31, 2019
7.57M109.80K+1.47%
Mar 31, 2018
7.46M-2.18M-22.61%
Mar 31, 2017
9.64M